Market View

The U.S. market remains in an Uptrend Under Pressure. Distribution on the Nasdaq remains elevated at seven days. The index still has an A/D Rating of E and price continues to hit resistance around its 50-DMA and a newly formed downward trending channel line. Additionally, the U.S. Focus List count has fallen from 68 to 60 names over the past three weeks, with ~30% of the current list trading below their 50-DMAs. Going forward, we will be looking for distribution to subside and for price/volume action to improve on both the major averages and lead-ership ideas alike. We maintain our cautious stance on the general market.

Stocks on our U.S. Focus List—Current Sentiment
Our USFL of 60 ideas gained 0.7% on average this week, in-line with the S&P 500 (0.7%) and the Nasdaq (0.8%).

By Sector
Multiple Technology ideas on the U.S. Focus List continue to act well. QTWO, WB, PAYC, NOW, RHT, CRM, TTWO, ALRM, and ADBE are all trading at or near new highs. MDSO and VEEV are the two outliers, each under pressure following Q2 earnings results from VEEV. Health Care ideas also improved, though all ideas remain in consolidation. VRTX continues to consolidate constructively above its 50-DMA. Conversely, our lone Basic Mate-rial name, USCR, broke its 50-DMA in heavy volume on the back of weakness across the Cement group. The stock is now sitting just above its 200-DMA.